Chronic hepatitis B virus (HBV) infection continues to pose a major global health threat. The virus evades immune responses ...

Precision BioSciences (DTIL) announced that the U.S. Food and Drug Administration or FDA has cleared the Investigational New Drug application ...

Hepatitis B virus infection remains one of the leading causes of liver disease, including cirrhosis and hepatocellular carcinoma.

Hepatitis B virus (HBV) is the leading cause of cirrhosis, hepatocellular carcinoma, and liver-related death globally.1,2 The highest prevalence is found in low-income and middle-income countries ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Tes HBsAG adalah salah satu skrining prenatal yang perlu dilakukan ibu hamil. Apa artinya jika HBsAG positif pada ibu hamil?

Gilead Sciences, Inc. (Nasdaq: GILD) today announced the presentation of late-breaking data and multiple oral presentations ...

and HBV DNA after 24 weeks' treatment to below the lower limit of detection in people with chronic hepatitis B, raising hopes that it could offer permanent cure, allowing safe termination of ...

Jaipur: In the wake of a tragic fatality caused by an erroneous blood transfusion at SMS Hospital in Feb 2024, the ...

University of Illinois at Urbana-Champaign researchers have developed a CRISPR-based diagnostic tool capable of detecting ...

A 35-year-old Nigerian national has been arrested by a joint security team at the Aflao Border for allegedly smuggling a ...

and HBV DNA loss to below the limits of detection in 9% to 10% of participants with chronic HBV infection. That is below the 30% rate reported at an interim stage of the study at the International ...